$4.260
-0.209 (-4.91%)At close
CGTL News
CGTL Events
Creative Global Receives Nasdaq Compliance Notification
Creative Global announced that the company received a notification letter from Nasdaq, notifying the company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550. The notification letter is based upon the fact that the closing bid price of the company's ordinary shares was below $1.00 per share for a period of 30 consecutive business days from May 13 to June 25.
Creative Global Tech Notified of Non-Compliance by Nasdaq
Creative Global Technology Holdings received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market, notifying the Company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2). The Notification Letter is based upon the fact that the closing bid price of the Company's Class A ordinary shares, no par value was below $1.00 per share for a period of 30 consecutive business days from July 28 to September 9. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until March 9, 2026, to regain compliance with Nasdaq's minimum bid price requirement. If at any time during the Compliance Period, the closing bid price per share of the Company's Ordinary Shares is at least $1.00 for a minimum of 10 consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with the minimum bid price requirement by March 9, 2026, the Company may be eligible for additional time of grace period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.





